New York State Common Retirement Fund Cure Vac N.V. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$13.18 - $19.41 $794,582 - $1.17 Million	-60,287 Reduced 99.98%	13 $0
Q1 2022 May 05, 2022	SELL	$14.73 - $35.25 $515 - $1,233	-35 Reduced 0.06%	60,300 $1.18 Million
Q4 2021 Feb 02, 2022	SELL	$33.72 - $48.22 $4,754 - $6,799	-141 Reduced 0.23%	60,335 $2.07 Million
Q3 2021 Nov 02, 2021	BUY	$49.26 - $74.5 $28,373 - $42,912	576 Added 0.96%	60,476 $3.3 Million
Q2 2021 Aug 02, 2021	BUY	$56.91 - $127.53 $3.41 Million - $7.64 Million	59,900 New	59,900 $4.4 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.